← Eichor
Study identifier: NCT07427446 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

Condition: Emergence Delirium  ·  Sponsor: Kasr El Aini Hospital

PhasePhase 4
Planned participants50
Who can joinAll sexes, 2 Years to 6 Years
Healthy volunteersNo

About this study

Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups. Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)

This description comes directly from the study's public registry record.

Talk to the study team

Ahmed Elhaddad, Ass.prof.  ·  01224042847  ·  drblacksmith@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kasralainy HospitalCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07427446